131 related articles for article (PubMed ID: 29073804)
21. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
22. Self-assembled liquid-crystalline folate nanoparticles for in vitro controlled release of doxorubicin.
Misra R; Mohanty S
Biomed Pharmacother; 2015 Feb; 69():326-36. PubMed ID: 25661378
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
[TBL] [Abstract][Full Text] [Related]
24. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
Cheng D; Cao N; Chen J; Yu X; Shuai X
Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
[TBL] [Abstract][Full Text] [Related]
26. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
27. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
Zhang C; Zhang Z; Zhao L
Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy.
Ak G; Yilmaz H; Güneş A; Hamarat Sanlier S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):926-937. PubMed ID: 29458269
[TBL] [Abstract][Full Text] [Related]
29. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
30. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
[TBL] [Abstract][Full Text] [Related]
31. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
Kayani Z; Bordbar AK; Firuzi O
Biomed Pharmacother; 2018 Nov; 107():945-956. PubMed ID: 30257407
[TBL] [Abstract][Full Text] [Related]
32. Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery.
Wang S; Wang H; Liu Z; Wang L; Wang X; Su L; Chang J
Nanoscale; 2014 Jul; 6(13):7635-42. PubMed ID: 24898341
[TBL] [Abstract][Full Text] [Related]
33. Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin.
Shalviri A; Chan HK; Raval G; Abdekhodaie MJ; Liu Q; Heerklotz H; Wu XY
Colloids Surf B Biointerfaces; 2013 Jan; 101():405-13. PubMed ID: 23010048
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
[TBL] [Abstract][Full Text] [Related]
35. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
36. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
Liu CW; Lin WJ
J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
[TBL] [Abstract][Full Text] [Related]
37. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
Tam YT; To KK; Chow AH
Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
[TBL] [Abstract][Full Text] [Related]
38. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
[TBL] [Abstract][Full Text] [Related]
39. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
40. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
